Product Images Doxazosin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Doxazosin NDC 50090-5773 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Table 1 - doxazosin fig1
This is a table summarizing the effectiveness data of placebo-controlled trials. The table shows maximum flow rate and symptom score data for each study, including the number of patients, baseline score, and change in score. Study 1 showcased maximum dose of Vatinum Fo, Study 2 showed fixed-dose and titration for 14 weeks, and Study 3 showed titration for 12 weeks. Different dosages of doxazosin were also compared to placebo. The questionnaire used for evaluating symptoms varied among the studies and ranged from 0 to 39; however, specific scores were not provided.*
Figure 1 – Study 1 - doxazosin fig2
Mean increase in maximum urinary flow rate and mean change in total symptom score from baseline were evaluated in a study with a placebo and doxazosin treatment. The study was conducted for a duration of weeks, and the maximum dosage for doxazosin was 8 mg. Compared to placebo, the results showed a statistically significant improvement (*p<0.05) in maximum urinary flow rate with doxazosin treatment. Furthermore, statistically significant improvement (+p < 0.05) in total symptom score was observed in comparison to baseline for both placebo and doxazosin treatment.*
Chemical Structure - doxazosin str
Label Image - lbl500905773
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.